Shanghai OPM Biosciences Co. Ltd. A688293
▼ NegativeCapitalrelevance
A major shareholder completed a share reduction, cashing out ~60.78 million yuan, reducing stake below 5%.

Aopumai shareholder Guoshou Chengda has completed its share reduction plan, selling a total of 1,392,719 shares through centralized bidding, with a total reduction amount of approximately 60.78 million yuan. The reduction period was from June 2 to July 9, 2026, with a reduction price range of 42.73 yuan to 45.40 yuan per share, and a reduction ratio of 0.98%. After this reduction, Guoshou Chengda's shareholding decreased to 6,538,966 shares, and its shareholding ratio dropped from 5.70% to 4.60%, making it no longer a shareholder holding more than 5% of the company.
Shanghai OPM Biosciences Co. Ltd. AA major shareholder completed a share reduction, cashing out ~60.78 million yuan, reducing stake below 5%.
OBiO Technology (Shanghai) Corp. Ltd. A